pacifica plus
bayer ag - Εναιωρηματοποιήσιμοι κόκκοι (wg) - Δραστικές ουσίες: amidosulfuron 5% β/β, iodosulfuron-methyl-sodium 1% β/β, mesosulfuron-methyl 3% β/β Αντιφυτοτοξικός παράγοντας: mefenpyr-diethyl 9% β/β Βοηθητικές ουσίες: 90,07% β/β
celiprolol hydrochloride/generics 200mg/tab f.c.tab
generics pharma hellas ΕΠΕ - celiprolol - ΕΠΙΚΑΛΥΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 200mg/tab - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
amodiaquine 200mg tablets
remedica ltd (0000003171) aharnon str., lemesos, 3056 - amodiaquine hydrochloride - tablets - 200mg - amodiaquine hydrochloride (0006398987) 200mg base - amodiaquine
efavirenz sandoz 600mg film coated tablets
sandoz gmbh (0000003704) biochemiestrasse 10, kundl, 6250 - efavirenz - film coated tablets - 600mg - efavirenz (8000001727) 600mg - efavirenz
imfinzi
astrazeneca ab - durvalumab - Καρκίνωμα, μη μικροκυτταρικός πνεύμονας - Αντινεοπλασματικοί παράγοντες - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).
acinic f.c.tab 500mg/tab
adelco a.e. ΧΡΩΜ. ΑΘΗΝ. ΑΦΟΙ Ε. ΚΟΛΟΚΟΤΡΩΝΗ ΠΕΙΡΑΙΩΣ 37 ΜΟΣΧΑΤΟ, 18346 ΑΘΗΝΑ 4819311-14 - mefenamic acid - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 500mg/tab - mefenamic acid 500mg - mefenamic acid
viperfav (αντιοροσ δηλητηριου οφεοσ) c/s.sol.in
vianex a.e. - specific immunoglobulins - ΠΥΚΝΟ ΔΙΑΛΥΜΑ ΓΙΑ ΠΑΡΑΣΚΕΥΗ ΔΙΑΛΥΜΑΤΟΣ ΠΡΟΣ ΕΓΧΥΣΗ - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ - specific immunoglobulins
tosuman berna 16% inj.sol
ΦΑΡΑΝ ΑΒΕΕ ΠΑΡΑΓΩΓΗΣ ΚΑΙ ΕΜΠΟΡΙΑΣ ΦΑΡΜΑΚΩΝ - specific immunoglobulins - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ - 16% - ΠΡΟΙΟΝ ΑΙΜΑΤΟΣ (ΠΑ) - specific immunoglobulins
curosurf sus.tr.ins 120mg/1,5ml
chiesi hellas aebe Πλ. Γερουλάνου & Ρένου Πόγγη 1, 17455 Αλιμος Αττικής 210.6179763 - pig lung surfactant; lecithin; acidic phospholipids; choline; phospholipids; proteins; cholesterol; triglycerides - sus.tr.ins (ΕΝΔΟΤΡΑΧΕΙΟΠΝΕΥΜΟΝΙΚΗ ΕΝΣΤΑΛΛΑΞΗ, ΕΝΑΙΩΡΗΜΑ) - 120mg/1,5ml - pig lung surfactant 80mg; lecithin 65,5%; acidic phospholipids 8,6%; choline 2%; phospholipids 20,9%; proteins 1%; cholesterol 0 < 1%; triglycerides 0 < 1% - natural phospholipids
curosurf sus.tr.ins 240mg/3ml vial
chiesi hellas aebe Πλ. Γερουλάνου & Ρένου Πόγγη 1, 17455 Αλιμος Αττικής 210.6179763 - pig lung surfactant; lecithin; acidic phospholipids; choline; phospholipids; proteins; cholesterol; triglycerides - sus.tr.ins (ΕΝΔΟΤΡΑΧΕΙΟΠΝΕΥΜΟΝΙΚΗ ΕΝΣΤΑΛΛΑΞΗ, ΕΝΑΙΩΡΗΜΑ) - 240mg/3ml vial - pig lung surfactant 80mg; lecithin 65,5%; acidic phospholipids 8,6%; choline 2%; phospholipids 20,9%; proteins 1%; cholesterol 0 < 1%; triglycerides 0 < 1% - natural phospholipids